Recent Advances in Gastrointestinal Cancers

 

Related Videos (117)

In this video, oncologist Ursina Teitelbaum, MD, provides an overview of reports from ASCO on the current state of  targeted therapies for cancers of the colon, pancreas, stomach and liver. Dr. Teitelbaum discusses studies of bevacizumab, cetuximab and the FOLFOX and FOLFIRI regimens in colorectal cancer; ruxolitinib, capecitabine and mGPS in pancreatic cancer; capecitabine, cisplatin, bevacizumab, ramucirumab and paclitaxel in the gastric cancers; and sorafenib in hepatocellular carcinoma.

 

Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®